抗抑郁药
参考资料

↑  Bodkin JA, Zornberg GL, Lukas SE, Cole JO. . Journal of Clinical Psychopharmacology. 1995, 15 (1): 49–57. PMID 7714228. doi:10.1097/00004714-199502000-00008.
↑  Wheeler Vega JA, Mortimer AM, Tyson PJ. . J Clin Psychiatry. 2003, 64 (5): 568–74. PMID 12755661. doi:10.4088/JCP.v64n0512.
1 2 3 4 5 6 7 8 9 10 11 12 13 14  Linde K, Berner MM, Kriston L. . Cochrane Database Syst Rev. 2008, (4): CD000448. PMID 18843608. doi:10.1002/14651858.CD000448.pub3.
↑  Ernst E. . Evidence-based mental health. August 2009, 12 (3): 78. PMID 19633246. doi:10.1136/ebmh.12.3.78.
↑  Pariante, Carmine M. . British Society for Neuroendocrinology, UK. 2017-04-12  [2017-04-12 l=yes]. （原始内容存档于2017年4月12日）.  请检查|access-date=中的日期值 (帮助)
1 2  Surget A, Tanti A, Leonardo ED,  et al. . Molecular Psychiatry. December 2011, 16 (12): 1177–88. PMC 3223314 . PMID 21537331. doi:10.1038/mp.2011.48.
↑   https://www.ncbi.nlm.nih.gov/books/NBK361016/
↑   https://evidence.nihr.ac.uk/alert/almost-half-people-long-term-antidepressants-stop-without-relapse/
↑   https://pubmed.ncbi.nlm.nih.gov/38733930/
↑  Hamilton M. . J. Neurol. Neurosurg. Psychiatr. 1960, 23: 56–62. PMC 495331 . PMID 14399272. doi:10.1136/jnnp.23.1.56.
↑  . NICE guidelines [CG90]. National Institute for Health and Care Excellence (UK). October 2009  [2015-09-23]. （原始内容存档于2015-09-23）.
↑  . （原始内容存档于2014-02-19）.
↑  Kirsch I, Moore TJ, Scoboria A, Nicholls SS. . Prevention & Treatment. 2002, 5. doi:10.1037/1522-3736.5.1.523a.
↑  . USA Today. 2002-07-07  [2008-11-06]. （原始内容存档于2009-02-04）.
↑  Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. . PLoS Medicine. 2008, 5 (2): e45. PMC 2253608 . PMID 18303940. doi:10.1371/journal.pmed.0050045.
↑  Jakobsen, JC; Katakam, KK; Schou, A; Hellmuth, SG; Stallknecht, SE; Leth-Møller, K; Iversen, M; Banke, MB; Petersen, IJ; Klingenberg, SL; Krogh, J; Ebert, SE; Timm, A; Lindschou, J; Gluud, C. . BMC Psychiatry. 2017-02-08, 17 (1): 58. PMC 5299662 . PMID 28178949. doi:10.1186/s12888-016-1173-2.
↑  Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J. . JAMA. 2010-01-06, 303 (1): 47–53. PMC 3712503 . PMID 20051569. doi:10.1001/jama.2009.1943.
↑
↑  Borges S, Chen YF, Laughren TP, Temple R, Patel HD, David PA, Mathis M, Unger E, Yang P, Khin NA. . J Clin Psychiatry. 2014, 75 (3): 205–14. PMID 24717376. doi:10.4088/JCP.13r08722.
↑   (PDF). National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Care Excellence. www.nice.org.uk: 282–292.   [2013-11-20]. （原始内容 (PDF)存档于2013-06-12）.
↑  Leucht C, Huhn M, Leucht S. Leucht C , 编. . Cochrane Database of Systematic Reviews. 2012, 12: CD009138. PMID 23235671. doi:10.1002/14651858.CD009138.pub2.
↑  Zhou X, Ravindran AV, Qin B, Del Giovane C, Li Q, Bauer M, Liu Y, Fang Y, da Silva T, Zhang Y, Fang L, Wang X, Xie P. . J Clin Psychiatry. April 2015, 76 (4): e487–98. PMID 25919841. doi:10.4088/JCP.14r09204. Quetiapine and aripiprazole appear to be the most robust evidence-based options for augmentation therapy in patients with treatment-resistant depression
1 2 3  Linde K, Kriston L, Rücker G, Jamila S, Schumann I, Meissner K, Sigterman K, Schneider A. . Ann Fam Med. February 2015, 13 (1): 69–79. PMC 4291268 . PMID 25583895. doi:10.1370/afm.1687. In network meta-analysis, tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), a serotonin-noradrenaline reuptake inhibitor (SNRI; venlafaxine), a low-dose serotonin antagonist and reuptake inhibitor (SARI; trazodone) and hypericum extracts were found to be significantly superior to placebo, with estimated odds ratios between 1.69 and 2.03. There were no statistically significant differences between these drug classes. Reversible inhibitors of monoaminoxidase A (rMAO-As) and hypericum extracts were associated with significantly fewer dropouts because of adverse effects compared with TCAs, SSRIs, the SNRI, a noradrenaline reuptake inhibitor (NRI), and noradrenergic and specific serotonergic antidepressant agents (NaSSAs). ... TCAs and SSRIs have the most solid evidence base. Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently available evidence makes a clear recommendation on their place in clinical practice difficult.
↑  Walsh BT, Seidman SN, Sysko R, Gould M. . JAMA. 2002, 287 (14): 1840–7. PMID 11939870. doi:10.1001/jama.287.14.1840.
↑  Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI. . J Clin Psychiatry. 2010, 71 (6): 682–8. PMID 20573327. doi:10.4088/JCP.10r05976blu.
↑  Lee K, Bacchetti P, Sim I. Clarke M , 编. . PLoS Medicine. 2008, 5 (9): e191. PMC 2553819 . PMID 18816163. doi:10.1371/journal.pmed.0050191.
↑  Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. . The Lancet. 2004, 363 (9418): 1341–5. PMID 15110490. doi:10.1016/S0140-6736(04)16043-1.
↑  Shanil Ebrahim. . Journal of Clinical Epidemology. 2015, 70: 155–63. PMID 26399904. doi:10.1016/j.jclinepi.2015.08.021. 简明摘要.
↑  Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ. . Archives of General Psychiatry. June 2012, 69 (6): 572–9. PMC 3371295 . PMID 22393205. doi:10.1001/archgenpsychiatry.2011.2044.
↑  Undurraga, Juan; Ross, Baldessarini. . Neuropsychopharmacology. 2012, 37: 851–864. PMC 3280655 . PMID 22169941. doi:10.1038/npp.2011.306.
↑  . National Institute of Mental Health.   [2012-11-28]. （原始内容存档于2013-03-05）.
↑  Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH. . The American Journal of Psychiatry. 2006, 163 (7): 1161–72. PMID 16816220. doi:10.1176/appi.ajp.163.7.1161.
1 2  Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ. . New England Journal of Medicine. 2006, 354 (12): 1243–52. PMID 16554526. doi:10.1056/NEJMoa052964.
↑  Cusin C, Yang H, Yeung A, Fava M.  (PDF). Baer L, Blais MA  (编). . New York: Springer. 2010: 7–36  [2017-10-30]. ISBN 9781588299666. （原始内容存档 (PDF)于2017-06-26）.
1 2   (PDF).   [2017-10-30]. （原始内容 (PDF)存档于2014-10-20）.
↑  Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M. . American Journal of Psychiatry. 2006, 163 (1): 28–40. PMID 16390886. doi:10.1176/appi.ajp.163.1.28.
↑  Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ. . Am J Psychiatry. 2007, 164 (8): 1189–97. PMID 17671281. doi:10.1176/appi.ajp.2007.06071225.
↑  Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M. . New England Journal of Medicine. 2006, 354 (12): 1231–42. PMID 16554525. doi:10.1056/NEJMoa052963.
↑  Rush AJ, Trivedi MH, Wisniewski SR,  et al. . Am J Psychiatry. November 2006, 163 (11): 1905–17. PMID 17074942. doi:10.1176/appi.ajp.163.11.1905.
↑  Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. . Current Psychiatry Reports. 2007, 9 (6): 449–59. PMID 18221624. doi:10.1007/s11920-007-0061-3.
↑  Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. . Archives of General Psychiatry. 2006, 63 (11): 1217–23. PMC 2211759 . PMID 17088502. doi:10.1001/archpsyc.63.11.1217.
↑  Baghai TC, Möller HJ, Rupprecht R. . Current Pharmaceutical Design. 2006, 12 (4): 503–15. PMID 16472142. doi:10.2174/138161206775474422.
1 2  Ruhé HG, Huyser J, Swinkels JA, Schene AH. . The Journal of Clinical Psychiatry. 2006, 67 (12): 1836–55. PMID 17194261. doi:10.4088/JCP.v67n1203.
↑  Tranter R, O'Donovan C, Chandarana P, Kennedy S. . Journal of Psychiatry & Neuroscience. 2002, 27 (4): 241–7. PMC 161658 . PMID 12174733.
↑  Byrne SE, Rothschild AJ. . The Journal of Clinical Psychiatry. 1998, 59 (6): 279–88. PMID 9671339. doi:10.4088/JCP.v59n0602.
↑  . www.cdc.gov. Products - Data Briefs - Number 76 - October 2011. Centers for Disease Control and Prevention.   [2016-02-04]. （原始内容存档于2016-02-04）.
↑  Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M. . Canadian Journal of Psychiatry. 2000, 45 (5): 476–81. PMID 10900529.
↑  Bschor T, Baethge C. . Acta Psychiatrica Scandinavica. 2010, 121 (3): 174–9. PMID 19703121. doi:10.1111/j.1600-0447.2009.01458.x.
↑  DeBattista C, Lembke A. . Current Psychiatry Reports. 2005, 7 (6): 435–40. PMID 16318821. doi:10.1007/s11920-005-0064-x.
↑  Lam RW, Wan DD, Cohen NL, Kennedy SH. . The Journal of Clinical Psychiatry. 2002, 63 (8): 685–93. PMID 12197448. doi:10.4088/JCP.v63n0805.
↑  Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. . The Journal of Clinical Psychiatry. 2013, 74 (11): 1101–7. PMID 24330897. doi:10.4088/JCP.13r08560.
↑  Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM. . The Lancet. 2003, 361 (9358): 653–61. PMID 12606176. doi:10.1016/S0140-6736(03)12599-8.
↑  Targum SD. . Innov Clin Neurosci. March 2014, 11 (3–4): 24–8. PMC 4008298 . PMID 24800130.
↑  Fava GA, Offidani E. . Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2011, 35 (7): 1593–602. PMID 20728491. doi:10.1016/j.pnpbp.2010.07.026.
↑  Fava GA, Park SK, Sonino N. . Expert Review of Neurotherapeutics. 2006, 6 (11): 1735–40. PMID 17144786. doi:10.1586/14737175.6.11.1735.
↑  Petersen TJ. . Journal of Psychopharmacology. 2006, 20 (3 suppl): 19–28. PMID 16644768. doi:10.1177/1359786806064314.
1 2 3 4 5 6 7  Brunton LL, Chabner B, Knollmann BC (编).  12th. New York: McGraw-Hill Professional. 2011. ISBN 978-0-07-162442-8.
1 2 3 4 5 6 7 8 9 10 11  . UpToDate. Wolters Kluwer Health.   [2013-10-24]. （原始内容存档于2013-11-02）.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  Royal Pharmaceutical Society of Great Britain. . Pharmaceutical Press.   [2013-10-31]. （原始内容存档于2013-07-26）.
1 2 3 4 5 6 7 8 9 10 11 12  Ernst E; Rand JI; Barnes J; Stevinson C. . European Journal of Clinical Pharmacology. 1998, 54 (8): 589–94. PMID 9860144. doi:10.1007/s002280050519. Collectively, the data suggest that hypericum is well tolerated, with an incidence of adverse reactions similar to that of placebo.
1 2 3  Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. . Lancet. 2009, 373 (9665): 746–58. PMID 19185342. doi:10.1016/S0140-6736(09)60046-5.
1 2 3 4 5 6 7 8 9 10 11 12  Taylor D, Paton C, Shitij K. . West Sussex: Wiley-Blackwell. 2012. ISBN 978-0-470-97948-8.
1 2  White N, Litovitz T, Clancy C. . J Med Toxicol. 2008, 4 (4): 238–50. PMC 3550116 . PMID 19031375. doi:10.1007/BF03161207.
1 2 3 4 5 6 7 8  Rossi, S (编).  2013. Adelaide: The Australian Medicines Handbook Unit Trust. 2013. ISBN 978-0-9805790-9-3.
1 2  van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J. . Int Clin Psychopharmacol. March 1995, 10 (1): 3–9. PMID 7622801. doi:10.1097/00004850-199503000-00001.
1 2 3 4 5 6 7 8 9 10 11  Voican, CS; Corruble, E; Naveau, S; Perlemuter, G. . The American Journal of Psychiatry. April 2014, 171 (4): 404–15. PMID 24362450. doi:10.1176/appi.ajp.2013.13050709.
↑  . DailyMed. Watson Laboratories, Inc. August 2010  [2013-10-30]. （原始内容存档于2013-11-02）.
1 2  Walker, R, Whittlesea, C (编).  4th. Edinburgh: Churchill Livingstone Elsevier. 2007 [1994]. ISBN 978-0-7020-4293-5.
↑  Bruijn JA, Moleman P, Mulder PG, van den Broek WW, van Hulst AM, van der Mast RC, van de Wetering BJ.  (PDF). Psychopharmacology. 1996, 127 (3): 231–7  [2017-10-31]. PMID 8912401. doi:10.1007/BF02246131. （原始内容存档 (PDF)于2017-08-18）.
↑  Bruijn JA, Moleman P, Mulder PG, van den Broek WW. . Pharmacopsychiatry. 1999, 32 (3): 87–92. PMID 10463374. doi:10.1055/s-2007-979200.
1 2  Fishback JA, Robson MJ, Xu YT, Matsumoto RR. . Pharmacol. Ther. 2010, 127 (3): 271–82. PMC 3993947 . PMID 20438757. doi:10.1016/j.pharmthera.2010.04.003.
1 2  Kishimoto A, Todani A, Miura J, Kitagaki T, Hashimoto K. . Ann Gen Psychiatry. 2010, 9: 23. PMC 2881105 . PMID 20492642. doi:10.1186/1744-859X-9-23.
↑  Borkowska A, Pilaczyńska E, Araszkiewicz A, Rybakowski J. . Psychiatr. Pol. 2002, 36 (6 Suppl): 289–95. PMID 12647451 （波兰语）.
↑  Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ. . J. Psychopharmacol. 2002, 16 (3): 207–14. PMID 12236626. doi:10.1177/026988110201600303.
↑  Joint Formulary Committee.  65. London, UK: Pharmaceutical Press. 2013. ISBN 978-0-85711-084-8.
↑  Goodwin GM. . CNS Drugs. 2009,. 23 Suppl 2: 35–9. PMID 19708724. doi:10.2165/11318650-000000000-00000.
1 2   (PDF).   [2013-02-20]. （原始内容 (PDF)存档于2012-10-21）.
1 2  Kapczinski F, Lima MS, Souza JS, Schmitt R. Kapczinski FF , 编. . Cochrane Database Syst Rev. 2003, (2): CD003592. PMID 12804478. doi:10.1002/14651858.CD003592.
↑   (PDF). （原始内容 (PDF)存档于2008-12-06）.
↑  Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, Macgillivray S. Arroll B , 编.  (PDF). Cochrane Database Syst Rev. 2009, (3): CD007954  [2017-10-31]. PMID 19588448. doi:10.1002/14651858.CD007954. （原始内容存档 (PDF)于2017-09-21）.
↑  .   [2015-01-30]. （原始内容存档于2013-04-13）.
↑  Fineberg, N. A.; Brown, A; Reghunandanan, S; Pampaloni, I. . The International Journal of Neuropsychopharmacology. 2012, 15 (8): 1173–91. PMID 22226028. doi:10.1017/S1461145711001829. hdl:2299/216.
↑   (PDF).   [2015-01-30]. （原始内容 (PDF)存档于2015-02-19）.
↑   (PDF).   [2015-01-30]. （原始内容存档 (PDF)于2015-06-16）.
1 2 3   (PDF). （原始内容存档 (PDF)于2014-03-27）.
↑  .   [2017-10-31]. （原始内容存档于2016-07-04）.
1 2  . （原始内容存档于2013-05-25）.
↑  Flament MF, Bissada H, Spettigue W. . Int. J. Neuropsychopharmacol. March 2012, 15 (2): 189–207. PMID 21414249. doi:10.1017/S1461145711000381.
↑  Häuser W, Wolfe F, Tölle T, Uçeyler N, Sommer C. . CNS Drugs. April 2012, 26 (4): 297–307. PMID 22452526. doi:10.2165/11598970-000000000-00000.
↑   (PDF). （原始内容 (PDF)存档于2014-05-23）.
↑  Lunn MP, Hughes RA, Wiffen PJ. . Cochrane Database Syst Rev. 2014, 1: CD007115. PMID 24385423. doi:10.1002/14651858.CD007115.pub3.
1 2  Moore, R. Andrew; Derry, Sheena; Aldington, Dominic; Cole, Peter; Wiffen, Philip J. . The Cochrane Database of Systematic Reviews. 2015-07-06, (7): CD008242. ISSN 1469-493X. PMID 26146793. doi:10.1002/14651858.CD008242.pub3.
↑  Birmes P, Coppin D, Schmitt L, Lauque D. . CMAJ. 2003, 168 (11): 1439–42. PMC 155963 . PMID 12771076.
↑  Boyer EW, Shannon M.  (PDF). N. Engl. J. Med. 2005, 352 (11): 1112–20. PMID 15784664. doi:10.1056/NEJMra041867. （原始内容 (PDF)存档于2013-06-18）.
↑  Mason PJ, Morris VA, Balcezak TJ. . Medicine. 2000, 79 (4): 201–9. PMID 10941349. doi:10.1097/00005792-200007000-00001.
↑  Sampson E, Warner JP. . Br J Gen Pract. 1999, 49 (448): 867–8. PMC 1313553 . PMID 10818648.
↑  Sathyanarayana Rao TS, Yeragani VK. . Indian J Psychiatry. 2009, 51 (1): 65–6. PMC 2738414 . PMID 19742203. doi:10.4103/0019-5545.44910.
↑  Paykel ES. . Acta Psychiatr Scand Suppl. 1995, 386: 22–7. PMID 7717091. doi:10.1111/j.1600-0447.1995.tb05920.x.
↑  Malm H. . Ther Drug Monit. December 2012, 34 (6): 607–14. PMID 23042258. doi:10.1097/FTD.0b013e31826d07ea.
↑  Rahimi R, Nikfar S, Abdollahi M. . Reproductive Toxicology. 2006, 22 (4): 571–575. PMID 16720091. doi:10.1016/j.reprotox.2006.03.019.
1 2  Nikfar S, Rahimi R, Hendoiee N, Abdollahi M. . Daru. 2012, 20 (1): 75. PMC 3556001 . PMID 23351929. doi:10.1186/2008-2231-20-75.
↑  Huang H, Coleman S, Bridge JA, Yonkers K, Katon W. . General Hospital Psychiatry. 2014, 36 (1): 13–8. PMC 3877723 . PMID 24094568. doi:10.1016/j.genhosppsych.2013.08.002.
↑  Einarson TR, Kennedy D, Einarson A. . J Popul Ther Clin Pharmacol. 2012, 19 (2): e334–48. PMID 22946124.
↑  Riggin L, Frankel Z, Moretti M, Pupco A, Koren G. . J Obstet Gynaecol Can. April 2013, 35 (4): 362–9. PMID 23660045.
↑  Koren G, Nordeng HM. . Semin Fetal Neonatal Med. February 2013, 18 (1): 19–22. PMID 23228547. doi:10.1016/j.siny.2012.10.004.
↑   (新闻稿). U.S. Food and Drug Administration.   [29 November 2012]. （原始内容存档于3 December 2013）.
↑  Ross, Lori E.; Grigoriadis, Sophie; Mamisashvili, Lana; VonderPorten, Emily H.; Roerecke, Michael; Rehm, Jürgen; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy. . JAMA Psychiatry. 2013-04-01, 70 (4): 436. doi:10.1001/jamapsychiatry.2013.684.
↑  Lanza di Scalea T, Wisner KL. . Clinical Obstetrics and Gynecology. 2009, 52 (3): 483–97. PMC 2902256 . PMID 19661763. doi:10.1097/GRF.0b013e3181b52bd6.
↑  Sivagnanam, G. . Journal of Pharmacology and Pharmacotherapeutics. 2012, 3 (3): 287–8  [2020-10-07]. （原始内容存档于2018-07-01）.
↑  Goldberg JF, Truman CJ. . Bipolar Disorders. 2003, 5 (6): 407–20. PMID 14636364. doi:10.1046/j.1399-5618.2003.00067.x.
↑  Benazzi F. . J Affect Disord. 1997, 46 (1): 73–7. PMID 9387089. doi:10.1016/S0165-0327(97)00082-7.
↑  Gitlin MJ. . International Journal of Bipolar Disorders. December 2018, 6 (1): 25. PMC 6269438 . PMID 30506151. doi:10.1186/s40345-018-0133-9 .
1 2 3  Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G. . BMJ. 2009, 339: b2880. PMC 2725270 . PMID 19671933. doi:10.1136/bmj.b2880.
↑  Friedman RA, Leon AC. . N. Engl. J. Med. 2007, 356 (23): 2343–6. PMID 17485726. doi:10.1056/NEJMp078015.
↑  . （原始内容存档于2016-12-19）.
↑   (PDF).   [2014-06-05]. （原始内容存档 (PDF)于2014-08-18）.
↑   (PDF). （原始内容存档 (PDF)于2012-10-18）.
↑  Healy D, Aldred G.  (PDF). International Review of Psychiatry. 2005, 17: 163–172. doi:10.1080/09540260500071624. （原始内容 (PDF)存档于2013-10-21）.
↑  Fornaro, Michele; Anastasia, Annalisa; Valchera, Alessandro; Carano, Alessandro; Orsolini, Laura; Vellante, Federica; Rapini, Gabriella; Olivieri, Luigi; Di Natale, Serena; Perna, Giampaolo; Martinotti, Giovanni; Di Giannantonio, Massimo; De Berardis, Domenico. . Frontiers in Psychiatry. 2019-05-03, 10. doi:10.3389/fpsyt.2019.00294.
↑  Lagerberg, Tyra; Fazel, Seena; Sjölander, Arvid; Hellner, Clara; Lichtenstein, Paul; Chang, Zheng. . Neuropsychopharmacology. 2022-03, 47 (4): 817–823. doi:10.1038/s41386-021-01179-z.
↑  Grant JE, Potenza MN (编). . Oxford: Oxford University Press. 2012. ISBN 978-0-19-538971-5.
↑  Csoka AB, Csoka A, Bahrick A, Mehtonen OP. . J Sex Med. 2008, 5 (1): 227–33. PMID 18173768. doi:10.1111/j.1743-6109.2007.00630.x.
↑  Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. . J Clin Psychiatry. 2001,. 62 Suppl 3: 10–21. PMID 11229449.
↑  Serretti A, Chiesa A. . J Clin Psychopharmacol. 2009, 29 (3): 259–66. PMID 19440080. doi:10.1097/JCP.0b013e3181a5233f.
↑  Chebili S, Abaoub A, Mezouane B, Le Goff JF. . Encephale. 1998, 24 (3): 180–4. PMID 9696909 （法语）.
↑  Keltner NL, McAfee KM, Taylor CL. . Perspectives in Psychiatric Care. 2009, 38 (3): 111–6. PMID 12385082. doi:10.1111/j.1744-6163.2002.tb00665.x.
↑  Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, Cansever A, Uzun O, Ozgen F, Ozsahin A. . Hum Psychopharmacol. 2008, 23 (4): 321–6. PMID 18278806. doi:10.1002/hup.929.
↑  Andersson KE, Mulhall JP, Wyllie MG. . BJU International. February 2006, 97 (2): 311–315. PMID 16430636. S2CID 34969671. doi:10.1111/J.1464-410x.2006.05911.X .
↑  Labbate LA, Grimes JB, Hines A, Pollack MH. . Annals of Clinical Psychiatry. December 1997, 9 (4): 241–5. PMID 9511948. doi:10.3109/10401239709147804.
↑  Modell, JG; Katholi, CR; Modell, JD; DePalma, RL. . Clinical pharmacology and therapeutics. 1997-04, 61 (4): 476–87. PMID 9129565. doi:10.1016/S0009-9236(97)90198-3.
↑  Stimmel GL, Dopheide JA, Stahl SM. . Pharmacotherapy. 1997, 17 (1): 10–21. PMID 9017762. doi:10.1002/j.1875-9114.1997.tb03674.x.
↑  . Medscape. WebMD.   [2013-11-19]. （原始内容存档于2013-10-29）.
↑  Papakostas GI. . J Clin Psychiatry. 2008, 69 (Suppl E1): 8–13. PMID 18494538.
↑  Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC. . Ann. Intern. Med. April 2005, 142 (7): 532–46. PMID 15809465. doi:10.7326/0003-4819-142-7-200504050-00012.
↑  . Wyeth Pharmaceuticals Inc. 2006  [2006-09-17]. （原始内容存档于2006-09-17）.
1 2 3  Gastaldon, Chiara; Schoretsanitis, Georgios; Arzenton, Elena; Raschi, Emanuel; Papola, Davide; Ostuzzi, Giovanni; Moretti, Ugo; Seifritz, Erich; Kane, John M.; Trifirò, Gianluca; Barbui, Corrado. . Drug Safety. December 2022, 45 (12): 1539–1549. ISSN 1179-1942. PMC 9676852 . PMID 36400895. doi:10.1007/s40264-022-01246-4.
1 2 3  Haddad, P. . Drug Saf. 2001, 24 (3): 183–97. PMID 11347722. doi:10.2165/00002018-200124030-00003.
1 2 3 4  Warner CH, Bobo W, Warner C, Reid S, Rachal J. . Am Fam Physician. August 2006, 74 (3): 449–56. PMID 16913164.
↑  Haddad, P.M.; Anderson, I.M. . Advances in Psychiatric Treatment. 2007, 13 (6): 447–457. doi:10.1192/apt.bp.105.001966.
↑  Renoir T. . Front Pharmacol. April 2013, 4: 45. PMC 3627130 . PMID 23596418. doi:10.3389/fphar.2013.00045.
↑  Haddad PM, Dursun SM. . Hum Psychopharmacol. January 2008, 23 (Suppl 1): 15–26. PMID 18098217. doi:10.1002/hup.918.